| scholarly article | Q13442814 |
| P2093 | author name string | J M White | |
| J A Levy | |||
| C D Weiss | |||
| P2860 | cites work | Oligomeric structure of a prototype retrovirus glycoprotein | Q24645144 |
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| The structure and function of the hemagglutinin membrane glycoprotein of influenza virus | Q29618354 | ||
| Viral and cellular membrane fusion proteins | Q34208540 | ||
| Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin | Q36217109 | ||
| Human immunodeficiency virus type 1-neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping | Q36780203 | ||
| Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein | Q37675018 | ||
| Protein-mediated membrane fusion | Q38648025 | ||
| Structure, function, and intracellular processing of paramyxovirus membrane proteins | Q39520071 | ||
| Characterization of human immunodeficiency virus type 2 envelope glycoproteins: dimerization of the glycoprotein precursor during processing | Q40100336 | ||
| Transmembrane envelope glycoproteins of human immunodeficiency virus type 2 and simian immunodeficiency virus SIV-mac exist as homodimers | Q40107953 | ||
| F protein-F protein interaction within the Sendai virus identified by native bonding or chemical cross-linking. | Q43416263 | ||
| Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV. | Q44021595 | ||
| MT-4 plaque formation can distinguish cytopathic subtypes of the human immunodeficiency virus (HIV). | Q45832873 | ||
| Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions | Q68948939 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5674-5677 | |
| P577 | publication date | 1990-11-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles | |
| P478 | volume | 64 |
| Q39583441 | A conformation-specific monoclonal antibody reacting with fusion-active gp41 from the human immunodeficiency virus type 1 envelope glycoprotein. |
| Q40428153 | A defective HIV-1 vector for gene transfer to human lymphocytes |
| Q42699474 | A mechanism by which binding of the broadly neutralizing antibody b12 unfolds the inner domain α1 helix in an engineered HIV-1 gp120. |
| Q33587774 | A non-canonical binding interface in the crystal structure of HIV-1 gp120 core in complex with CD4 |
| Q54155492 | A trimeric structural domain of the HIV-1 transmembrane glycoprotein |
| Q40789537 | Additive effect of tunicamycin and dextran sulfate on the binding of monoclonal antibody to the V2 domain of the envelope glycoprotein 120 of human immunodeficiency virus type 1. |
| Q45237075 | Antibody Epitopes Sensitive to the State of Human Immunodeficiency Virus Type 1 gp41 Oligomerization Map to a Putative α-Helical Region |
| Q35930918 | Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies |
| Q40893347 | Application of monoclonal antibodies to monitor the synthesis of a glycoprotein core of envelope glycoproteins of human immunodeficiency virus (HIV-1). |
| Q35700066 | Assembly, structure, and antigenic properties of virus-like particles rich in HIV-1 envelope gp120. |
| Q34050712 | Assessment of HIV vaccine development: past, present, and future |
| Q67944238 | Biochemical and biophysical characterization of the reovirus cell attachment protein sigma 1: evidence that it is a homotrimer |
| Q35774051 | Biochemically Defined HIV-1 Envelope Glycoprotein Variant Immunogens Display Differential Binding and Neutralizing Specificities to the CD4-binding Site |
| Q34302085 | Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants |
| Q36654947 | Characterization of stable Chinese hamster ovary cells expressing wild-type, secreted, and glycosylphosphatidylinositol-anchored human immunodeficiency virus type 1 envelope glycoprotein. |
| Q36655317 | Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding |
| Q36434294 | Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites |
| Q27732646 | Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly |
| Q35832875 | Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure. |
| Q30442126 | Dilation of the Human Immunodeficiency Virus–1 Envelope Glycoprotein Fusion Pore Revealed by the Inhibitory Action of a Synthetic Peptide from gp41 |
| Q36288363 | Early assembly step of a retroviral envelope glycoprotein: analysis using a dominant negative assay. |
| Q35666057 | Engineering, Expression, Purification, and Characterization of Stable Clade A/B Recombinant Soluble Heterotrimeric gp140 Proteins |
| Q41642845 | Expression of bovine immunodeficiency-like virus envelope glycoproteins by a recombinant baculovirus in insect cells |
| Q36684443 | Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein |
| Q35665842 | HIV-1 Clinical Isolates Resistant to CCR5 Antagonists Exhibit Delayed Entry Kinetics That Are Corrected in the Presence of Drug |
| Q24645525 | HIV-1 entry inhibitors: an overview |
| Q27003887 | HIV-1 entry inhibitors: recent development and clinical use |
| Q35878159 | Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic alpha-helical/leucine zipper-like sequence |
| Q36365085 | Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer |
| Q40567149 | Human immunodeficiency virus type 1-associated CD4 downmodulation. |
| Q35854300 | Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein. |
| Q41093377 | Increased Incorporation of Chimeric Human Immunodeficiency Virus Type 1 gp120 Proteins into Pr55gagVirus-like Particles by an Epstein–Barr Virus gp220/350-Derived Transmembrane Domain |
| Q74412093 | Interactions between HIV-1 gp120, chemokines, and cultured adult microglial cells |
| Q36650157 | Interference with superinfection and with cell killing and determination of host range and growth kinetics mediated by feline leukemia virus surface glycoproteins. |
| Q35192782 | Mechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 |
| Q33933319 | Mechanisms of enveloped virus entry into animal cells |
| Q24630280 | Multimeric CD4 binding exhibited by human and simian immunodeficiency virus envelope protein dimers |
| Q34070049 | Mutation-directed chemical cross-linking of human immunodeficiency virus type 1 gp41 oligomers. |
| Q28646740 | Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity |
| Q36633402 | Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. |
| Q36797314 | Oligomer formation of the gB glycoprotein of herpes simplex virus type 1 |
| Q39876081 | Oligomeric structure of glycoproteins in herpes simplex virus type 1. |
| Q34343380 | Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface |
| Q33952715 | Oligomeric structure of virion-associated and soluble forms of the simian immunodeficiency virus envelope protein in the prefusion activated conformation |
| Q35838506 | Oligomerization of the hydrophobic heptad repeat of gp41. |
| Q24634681 | Pathogenesis of human immunodeficiency virus infection |
| Q35818505 | Peptide inhibitors of virus-cell fusion: enfuvirtide as a case study in clinical discovery and development |
| Q41671793 | Protein-protein interactions in lymphocytic choriomeningitis virus |
| Q30499590 | Quaternary structures of HIV Env immunogen exhibit conformational vicissitudes and interface diminution elicited by ligand binding |
| Q27642457 | Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop |
| Q30865013 | Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells |
| Q73489084 | Self-association of truncated forms of HIV-1 gp120 |
| Q45757977 | Short Communication: Immunogenicity of DNA Vaccines Expressing Human Immunodeficiency Virus Type 1 Envelope Glycoprotein with and without Deletions in the V1/2 and V3 Regions |
| Q37827167 | Small molecule HIV entry inhibitors: Part I. Chemokine receptor antagonists: 2004 – 2010 |
| Q37594056 | Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like regio |
| Q28188544 | The HIV Env-mediated fusion reaction |
| Q22242262 | The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens |
| Q38335350 | The N-terminal heptad repeat region of reovirus cell attachment protein sigma 1 is responsible for sigma 1 oligomer stability and possesses intrinsic oligomerization function |
| Q41776844 | The SCHOOL of nature. IV. Learning from viruses |
| Q28646857 | The ectodomain of HIV-1 env subunit gp41 forms a soluble, alpha-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide |
| Q36669879 | The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. |
| Q27469663 | The human immunodeficiency virus type 1 gp120 V2 domain mediates gp41-independent intersubunit contacts |
| Q41020949 | The life-cycle of human immunodeficiency virus type 1 |
| Q45784857 | The role of calcium and N-linked glycans in the oligomerization and carbohydrate binding properties of human immunodeficiency virus external envelope glycoprotein |
| Q34306883 | The tale of the long tail: the cytoplasmic domain of HIV-1 gp41. |
| Q36685908 | Transdominant inhibition of wild-type human immunodeficiency virus type 2 replication by an envelope deletion mutant. |
| Q48080098 | Transmembrane protein polymorphisms and resistance to T-20 (Enfuvirtide, Fuzeon) in HIV-1 infected therapy-naive seroconverters and AIDS patients under HAART-T-20 therapy |
| Q36626279 | Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain |
| Q41146586 | Use of persistent infections with vaccinia virus recombinants to introduce alterations in foreign proteins: an application to HIV-1 env protein |
| Q37344402 | Viral pathogenesis, modulation of immune receptor signaling and treatment |
| Q41892359 | Viroporin potential of the lentivirus lytic peptide (LLP) domains of the HIV-1 gp41 protein |
| Q36701542 | gp160, the envelope glycoprotein of human immunodeficiency virus type 1, is a dimer of 125-kilodalton subunits stabilized through interactions between their gp41 domains |
Search more.